The expanded licence deal encompasses access to computational software, designed to facilitate and enhance innovation in both conventional and AI-based approaches to drug discovery
Cadence broadens Pfizer’s licence to molecular design software. (Credit: Louis Reed on Unsplash)
Cadence Molecular Sciences, a division of Cadence Design Systems, announced that Pfizer has agreed to extend and broaden its access to Cadence’s range of products and programming toolkits designed for advanced molecular design.
The computational software provided by Cadence Molecular Sciences, which is founded on physics and AI-based modelling, along with cheminformatics, serves as a catalyst for innovation in early-stage drug discovery.
This software is actively utilised by major pharmaceutical and biotech companies across the globe to expedite and propel advancements in therapeutic research.
Cadence Molecular Sciences corporate vice president Anthony Nicholls said: “We’re excited to continue to support Pfizer as they innovate across their therapeutic portfolio, utilising this unique set of research tools to aid in their early-stage drug discovery process.
“As we expand this agreement with Pfizer, we hope to continue to enable high-quality science at the frontier of medicine.”
Pfizer Digital R&D Solutions vice president Sergio Rotstein said: “Cadence’s molecular design technology continues to be an important resource to help us progress our early scientific discovery efforts across our therapeutic portfolio.”
Cadence is a prominent leader in the field of electronic design, leveraging more than 30 years of experience in computational software.
The company employs its foundational Intelligent System Design strategy to provide a comprehensive range of software, hardware, and IP solutions, all geared towards transforming design concepts into tangible reality.
Cadence serves an esteemed customer base consisting of some of the world’s most innovative companies. These customers are instrumental in delivering groundbreaking electronic products, spanning from microchips and circuit boards to complete systems, across a spectrum of dynamic market segments.
These applications encompass hyperscale computing, 5G communications, automotive, mobile technology, aerospace, consumer electronics, industrial sectors, and healthcare.